Underwater removal of small gastric neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This trial tests a special underwater technique to remove small type I gastric neuroendocrine tumors (5-9 mm) during an endoscopy. The goal is to see if it is safe and effective, which could offer a less invasive treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a small (5-9 mm) type I gastric neuroendocrine tumor seen during an endoscopy
- You are healthy enough for an endoscopic procedure and sedation
- The tumor does not show signs of deep invasion or other high-risk features
- You agree to the procedure by signing a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive methods to remove small rectal neuroendocrine tumors (less than 1 cm) during a colonoscopy. It may help patients avoid major surgery while still effectively treating the tumor.
This study looks at removing small rectal neuroendocrine tumors using an endoscope (a thin camera tool) instead of open surgery. It may help people with very small tumors if the doctors think you can safely have this procedure and the cancer has not spread to lymph nodes or distant organs.
This trial tests two endoscopic techniques (mEMR-C and mEMR-L) to remove small rectal neuroendocrine tumors. It may help patients with tumors 10 mm or smaller who want a less invasive treatment option.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests a new robotic system (Endorobotics) to remove early-stage stomach or colon tumors using an endoscope (a thin, flexible tube with a camera). The goal is to see if the robot helps doctors remove the entire tumor safely and effectively, especially when standard methods are challenging.
This trial looks at people (18 or older) who already had a digestive tract tumor removed using an endoscopy procedure. It may help doctors learn how this approach works and what outcomes to expect after removal.
Hear when a new Stomach Neuroendocrine Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.